Inst Diagnosti (INDISA) - Net Assets

Latest as of June 2025: CL$114.04 Billion CLP ≈ $127.53 Million USD

Based on the latest financial reports, Inst Diagnosti (INDISA) has net assets worth CL$114.04 Billion CLP (≈ $127.53 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CL$305.25 Billion ≈ $341.38 Million USD) and total liabilities (CL$191.22 Billion ≈ $213.85 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Inst Diagnosti liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CL$114.04 Billion
% of Total Assets	37.36%
Annual Growth Rate	8.08%
5-Year Change	28.68%
10-Year Change	92.43%
Growth Volatility	3.52

Inst Diagnosti - Net Assets Trend (2014–2024)

This chart illustrates how Inst Diagnosti's net assets have evolved over time, based on quarterly financial data. Also explore Inst Diagnosti asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for Inst Diagnosti (2014–2024)

The table below shows the annual net assets of Inst Diagnosti from 2014 to 2024. For live valuation and market cap data, see INDISA stock market capitalisation.

Year	Net Assets	Change
2024-12-31	CL$109.16 Billion ≈ $122.07 Million	+4.94%
2023-12-31	CL$104.02 Billion ≈ $116.33 Million	+2.28%
2022-12-31	CL$101.70 Billion ≈ $113.74 Million	+6.87%
2021-12-31	CL$95.17 Billion ≈ $106.43 Million	+12.19%
2020-12-31	CL$84.82 Billion ≈ $94.86 Million	+3.55%
2019-12-31	CL$81.92 Billion ≈ $91.61 Million	+7.67%
2018-12-31	CL$76.08 Billion ≈ $85.09 Million	+10.27%
2017-12-31	CL$69.00 Billion ≈ $77.16 Million	+9.43%
2016-12-31	CL$63.05 Billion ≈ $70.51 Million	+11.15%
2015-12-31	CL$56.73 Billion ≈ $63.44 Million	+13.09%
2014-12-31	CL$50.16 Billion ≈ $56.10 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Inst Diagnosti's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 34.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	CL$46.11 Billion	42.24%
Other Components	CL$63.05 Billion	57.76%
Total Equity	CL$109.16 Billion	100.00%

Inst Diagnosti Competitors by Market Cap

The table below lists competitors of Inst Diagnosti ranked by their market capitalization.

Company	Market Cap
Shanghai Tianyong Engineering Co Ltd SHG:603895	$453.43 Million
Leenos Corp KQ:039980	$453.43 Million
Guangdong New Grand Long Packing Co Ltd SHE:002836	$453.46 Million
Yunnan Metropolitan Real Estate Development Co Ltd SHG:600239	$453.48 Million
EVS Broadcast Equipment SA BR:EVS	$453.30 Million
China Datang Corporation Renewable Power Co. Limited F:DT7	$453.22 Million
Dalian Zhiyun Automation Co Ltd SHE:300097	$453.06 Million
Beijing Transtrue Technology Inc SHE:002771	$453.06 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Inst Diagnosti's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 104,019,753,000 to 109,156,351,000, a change of 5,136,598,000 (4.9%).
Net income of 7,275,926,000 contributed positively to equity growth.
Dividend payments of 43,688,000 reduced retained earnings.
Other factors decreased equity by 2,095,640,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CL$7.28 Billion	+6.67%
Dividends Paid	CL$43.69 Million	-0.04%
Other Changes	CL$-2.10 Billion	-1.92%
Total Change	CL$-	4.94%

Book Value vs Market Value Analysis

This analysis compares Inst Diagnosti's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 3.52x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 5.41x to 3.52x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	CL$489.58	CL$2648.30	x
2018-12-31	CL$539.87	CL$2648.30	x
2019-12-31	CL$581.26	CL$2648.30	x
2020-12-31	CL$601.89	CL$2648.30	x
2021-12-31	CL$675.27	CL$2648.30	x
2022-12-31	CL$701.65	CL$2648.30	x
2023-12-31	CL$738.09	CL$2648.30	x
2024-12-31	CL$753.09	CL$2648.30	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Inst Diagnosti utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 6.67%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 3.04%
• Asset Turnover: 0.88x
• Equity Multiplier: 2.50x
Recent ROE (6.67%) is below the historical average (14.84%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	23.40%	11.32%	0.93x	2.23x	CL$6.72 Billion
2015	23.15%	11.23%	0.86x	2.39x	CL$7.46 Billion
2016	20.51%	10.08%	0.83x	2.45x	CL$6.63 Billion
2017	17.23%	8.59%	0.87x	2.32x	CL$4.99 Billion
2018	19.31%	10.11%	0.89x	2.15x	CL$7.09 Billion
2019	14.20%	7.74%	0.89x	2.06x	CL$3.44 Billion
2020	4.13%	2.51%	0.76x	2.15x	CL$-4.98 Billion
2021	21.70%	10.95%	0.82x	2.43x	CL$11.13 Billion
2022	12.83%	6.82%	0.70x	2.68x	CL$2.88 Billion
2023	0.14%	0.07%	0.79x	2.66x	CL$-10.26 Billion
2024	6.67%	3.04%	0.88x	2.50x	CL$-3.64 Billion

Industry Comparison

This section compares Inst Diagnosti's net assets metrics with peer companies in the Medical Care Facilities industry.

No peer company data available for comparison.

About Inst Diagnosti

SN:INDISA Chile Medical Care Facilities

Market Cap

$453.40 Million

CL$405.42 Billion CLP

Market Cap Rank

#13057 Global

#55 in Chile

Share Price

CL$2648.30

Change (1 day)

+0.00%

52-Week Range

CL$1982.90 - CL$2889.90

All Time High

CL$2889.90